Duck Egg White-Derived Peptide VSEE (Val-Ser-Glu-Glu) Regulates Bone and Lipid Metabolisms by Wnt/β-Catenin Signaling Pathway and Intestinal Microbiota

Mol Nutr Food Res. 2019 Dec;63(24):e1900525. doi: 10.1002/mnfr.201900525. Epub 2019 Nov 8.

Abstract

Scope: Val-Ser-Glu-Glu (VSEE), identified from duck egg white peptides, has been proven to facilitate calcium absorption in a previous study. Since prevention of osteoporosis is important, it might act as a potential cofactor in osteoporosis prevention. Therefore, the aim of this study is to investigate the regulation of VSEE on osteoporosis and abnormal lipid metabolisms.

Methods and results: MC3T3-E1 cell and ovariectomized (OVX) rat model are used to evaluate VSEE on regulation of bone and lipid metabolisms. Differentiation and matrix mineralization of preosteoblast are significantly increased by VSEE (p <0.05), which attributed to stimulating calcium influx, then to activating Wnt/β-catenin signaling pathway and regulating runt-related transcription factor 2 and osteoprotegerin. VSEE can cross Caco-2/HT-29 co-cultured monolayer via paracellular pathway and peptide transporter 1 (PepT1), and can be detected in blood and maximum concentration is 122.84 ± 3.68 mg L-1 at 60 min. Additionally, VSEE reverses bone loss and regulate dyslipidemia through Wnt/β-catenin signaling pathway in OVX rats. Firmicutes phylum, Veillonellaceae, Prevotellaceae and six genera in VSEE group are significantly different compared with the Model group (p < 0.05).

Conclusion: VSEE promotes bone growth and inhibit abnormal lipid metabolism in an OVX model through the regulation of intestinal microbiota compositions and Wnt/β-catenin signal pathway.

Keywords: Val-Ser-Glu-Glu; Wnt/β-catenin signaling pathway; intestinal microbiota; osteoporosis; pharmacokinetic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Development / drug effects*
  • Caco-2 Cells
  • Ducks
  • Egg White / chemistry*
  • Female
  • Gastrointestinal Microbiome / drug effects*
  • HT29 Cells
  • Humans
  • Lipid Metabolism / drug effects*
  • Oligopeptides / metabolism
  • Oligopeptides / pharmacology*
  • Osteoblasts / drug effects
  • Osteoporosis, Postmenopausal / prevention & control
  • Rats
  • Rats, Sprague-Dawley
  • Wnt Signaling Pathway / drug effects
  • Wnt Signaling Pathway / physiology*
  • beta Catenin / physiology*

Substances

  • Oligopeptides
  • beta Catenin